SFO
TECH icon

Standard Family Office’s Bio-Techne TECH Stock Holding History

Standard Family Office’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,832
Closed -$201K – 393
2022
Q3 		$201K Hold
2,832
– – 0.09% 35
2022
Q2 		$245K Buy
2,832
+1,588
+128% +$149K 2.43% 8
2022
Q1 		$135K Sell
1,244
-400
-24% -$41.3K 0.04% 25
2021
Q4 		$213K Buy
1,644
+844
+106% +$103K 1.89% 12
2021
Q3 		$97K Sell
800
-4,740
-86% -$577K 0.03% 22
2021
Q2 		$624K Buy
5,540
+800
+17% +$84.2K 0.13% 75
2021
Q1 		$453K Sell
4,740
-800
-14% -$73K 0.11% 73
2020
Q4 		$440K Buy
+5,540
New +$401K 0.11% 76

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Standard Family Office's TECH Position: Q4 2022 in Review

Standard Family Office sold out of Bio-Techne (TECH) in Q4 2022, closing a stake of 2,832 shares — an estimated $201K sold.

Standard Family Office first reported a position in TECH in Q4 2020 and held it in 8 quarters. The position peaked at $624K in Q2 2021. 545 funds tracked by Wall St. Rank hold TECH as of Q4 2022.

  • Standard Family Office reported no remaining Bio-Techne position as of Q4 2022 after selling out during the quarter.
  • Standard Family Office sold 2,832 Bio-Techne shares in Q4 2022, an estimated $201K.
  • Standard Family Office first reported a position in Bio-Techne in Q4 2020 and held it in 8 quarters.
  • Standard Family Office's Bio-Techne position peaked at $624K in Q2 2021.
  • 545 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.